Početna › Rak mjehura › Texas › Austin
Kliničke studije za Rak mjehura u gradu Austin, TX
12 studija za Rak mjehura traži sudionike na lokacijama u gradu Austin i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.
Službeni tekst studije (engleski)
Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
U tijeku regrutacijaFaza 2
- Texas Oncology-Austin Central ( Site 0107), Austin
- Urology Austin, PLLC ( Site 0109), Austin
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
U tijeku regrutacijaFaza 3
- Texas Oncology, Austin
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
U tijeku regrutacijaFaza 1/2
- Texas Oncology - Central/South Texas, Austin
- Texas Oncology - Central/South Texas, Austin
- Texas Oncology - Central/South Texas, Austin
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
U tijeku regrutacijaFaza 3
- USO-Texas Oncology-Central/South Texas, Austin
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
U tijeku regrutacijaFaza 1/2
- Texas Oncology (Balcones) - SCRI, Austin
A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)
U tijeku regrutacijaFaza 1/2
- Urology Austin, PLLC ( Site 0008), Austin
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
U tijeku regrutacijaFaza 2
- Urology Austin, PLLC (Urology America), Austin
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
U tijeku regrutacijaFaza 2
- Urology Austin, LLC, Austin
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
U tijeku regrutacijaFaza 1/2
- Urology Austin, Austin
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
U tijeku regrutacijaFaza 2/3
- Local Institution - 0187, Austin
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
U tijeku regrutacija
- Austin Urology Institute, Austin
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
- Elligo Health Research, Inc., Austin
Studije za Rak mjehura u drugim gradovima
- New York City, NY35 studija
- Nashville, TN31 studija
- Houston, TX31 studija
- Dallas, TX27 studija
- Boston, MA26 studija
- Washington, DC26 studija
- Los Angeles, CA24 studija
- Baltimore, MD24 studija
- St. Louis, MO22 studija
- Philadelphia, PA21 studija
- Seattle, WA21 studija
- Edison, NJ21 studija
Ostale studije u gradu Austin
- Nemikrocelularni karcinom pluća30 studija
- Rak (sve vrste)20 studija
- Debljina20 studija
- Metastatski karcinom19 studija
- Kolorektalni rak19 studija
- Srčano zatajenje18 studija
- Rak dojke18 studija
- Prekomjerna tjelesna masa18 studija
- Rak jajnika17 studija
- Rak endometrija15 studija
- Rak prostate15 studija
- Depresija14 studija
Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.